WEIFANG, Shandong Province, China, May 19 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC:SGTI) (BULLETIN BOARD: SGTI) ('Shengtai Pharmaceutical' or 'the Company'), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that the Company's management will present at two upcoming investor conferences, including the Brean Murray, Carret & Co. All-Cap All-China Conference in New York City and the Roth China Discovery Tour in China. Brean Murray, Carret & Co. All-Cap, All-China Conference Date: Monday, May 19, 2008 Time: 1:15 p.m. EST Time Venue: Jade Room, the Waldorf Astoria, New York City This conference will feature formal presentations and one-on-one meetings with over 100 Chinese companies. Interested parties and investors may find more information by contacting the BMC Conference Coordinator, Barbara Bradley at (212) 702-6616 or . Roth China Discovery Tour Date: Tuesday, May 20, 2008 Time: 8:00 a.m. China Time Venue: Hotel Regent, Beijing, China The Roth China Discovery Tour will bring together executives from more than 60 companies in 7 cities throughout China. The event will combine factory visits with management presentations in a mini-conference format. Interested parties and institutional investors may find more information by e-mailing and referencing ROTH China Discovery Tour 2008. About Shengtai Pharmaceutical, Inc. Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of glucose products, which include pharmaceutical grade glucose used for medical purposes, and glucose and cornstarch products for the food and beverage industry and for industrial production in China. For more information about Shengtai Pharmaceutical, Inc. please visit http://www.shengtaipharmaceutical.com/ . For more information, please contact: Company Contact: Ms. Melody Shi CFO Shengtai Pharmaceutical, Inc. Tel: +1-949-468-7078 Email: Investor Relations Contact: Mr. Crocker Coulson President CCG Elite Investor Relations Tel: +1-646-213-1915 (NY Office) Email: Web: http://www.ccgelite.com/ DATASOURCE: Shengtai Pharmaceutical, Inc. CONTACT: Ms. Melody Shi, CFO of Shengtai Pharmaceutical, Inc., +1-949- 468-7078, or ; or Mr. Crocker Coulson, President of CCG Elite Investor Relations, +1-646-213-1915 (NY Office), or , for SGTI Web Site: http://www.ccgelite.com/ http://www.shengtaipharmaceutical.com/

Copyright